For people living with hereditary angioedema (#HAE), getting the right care isn't always straightforward. Navigating a rare disease is challenging enough on its own, and for some people in underserved communities, additional barriers to diagnosis, care and support may further complicate the journey. Equitable care means meeting people where they are—across every community, background and lived experience. We’re committed to doing our part: listening to the HAE community, expanding educational opportunities and working to help close the gaps. Learn more about our work: https://lnkd.in/eB_8Mrsb
概要
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines
- ウェブサイト
-
https://www.takeda.com/
Takedaの外部リンク
- 業種
- 医薬品製造業
- 会社規模
- 社員 10,001名以上
- 本社
- Tokyo
- 種類
- 上場企業
- 創立
- 1781
- 専門分野
- Pharmaceuticals、Therapeutics、Oncology、Gastroenterology、Vaccines
場所
Takedaの社員
アップデート
-
Purpose and rigor go hand in hand across every stage of innovation. From early research through development and beyond, progress happens when people across disciplines challenge ideas, push science forward and stay connected to the patients behind the work. Explore how our teams are advancing oncology with purpose, and discover open opportunities at Takeda: https://bit.ly/4ftW0DE #TeamTakeda #MakeHistoryChangeFutures #BioPharmaHiring #ResearchAndDevelopment #Biotech
-
-
As head of patient safety and pharmacovigilance affiliate management, Jin Vermaat, had a leading role in a cross-functional initiative that implemented electronic product leaflets. Besides improving patient accessibility, they also help us to significantly reduce resources used to communicate product safety information. Jin shares how the benefits for patients, the environment, and the business make overcoming challenges rewarding. #Sustainability #PatientCentric
-
"It's not the destination, it's the journey." The same could be said for innovation in pharmaceuticals. Innovation doesn't happen in a single breakthrough or within one function. It happens throughout the product journey, through the collaboration of people across research, development, manufacturing, data science, operations and more. Every role contributes to moving science forward and helping deliver better outcomes for patients. Read more about how collaboration across teams drives innovation at Takeda: https://bit.ly/4pvp7ej #TeamTakeda #GlobalCareers #BioPharmaHiring #ResearchAndDevelopment
-
-
We are proud to share our dengue vaccine has been approved by India’s Central Drugs Standard Control Organization (CDSCO) — marking the first dengue vaccine approval in India. This milestone comes at a critical moment, as reported dengue cases continue to increase globally, and transmission patterns become increasingly unpredictable. As one of the world’s largest dengue-endemic countries, India carries a significant weight of the global dengue burden. This approval represents an important step forward in helping strengthen dengue prevention efforts for communities most impacted by the disease. Takeda remains committed to advancing innovation and expanding access to help address the growing global challenge of dengue.
-
At #AADInnovation2026, we presented new data from two pivotal Phase 3 studies of our investigational oral treatment for people with moderate-to-severe plaque #psoriasis, including results across high-impact sites. Read more here: https://lnkd.in/e3-FZ58G
-
-
To help create a healthier world for patients and the communities where we operate, we are working to reduce our environmental footprint. We are taking decisive action with ambitious, science-based targets to reach net-zero emissions across our value chain by FY2040. Learn more about the actions that are helping us make progress in our Annual Integrated Report: https://lnkd.in/ejgrpHG4
-
-
Everything we do starts with a shared goal: creating better possibilities for patients. No matter our role, we each contribute to that mission. Whether we're advancing research, applying data and AI, supporting manufacturing or leading projects, our work comes together to help make an impact for the people we serve. Discover how our teams turn innovation into impact for patients: https://bit.ly/4bOkOVR #TeamTakeda #GlobalCareers #BioPharmaHiring #LifeSciences
-
From a single molecule to a potentially life-changing therapy, drug development is a journey of discovery, precision and teamwork. Our Oncology teams connect science and data every step of the way to help bring new possibilities to patients faster. Explore how innovation comes to life and the scientists making it happen: https://bit.ly/4w0b0QN #TeamTakeda #Oncology #Innovation
-